124 related articles for article (PubMed ID: 845486)
1. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
Ali M; McDonald JW
J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
[TBL] [Abstract][Full Text] [Related]
2. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
Hatmi M; del Maschio A; Lefort J; de gaetano G; Vargaftig BB; Cerletti C
J Pharmacol Exp Ther; 1987 May; 241(2):623-7. PubMed ID: 3106620
[TBL] [Abstract][Full Text] [Related]
3. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
4. Conditions influencing platelet lysis.
Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
[TBL] [Abstract][Full Text] [Related]
5. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
[TBL] [Abstract][Full Text] [Related]
6. The action of halofenate on platelet shape change and prostaglandin synthesis.
Favis GR; Colman RW
J Lab Clin Med; 1978 Jul; 92(1):45-52. PubMed ID: 659964
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
8. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro.
Alarayyed NA; Prichard BN; Betteridge DJ; Smith CC
Platelets; 2002; 13(5-6):267-71. PubMed ID: 12189011
[TBL] [Abstract][Full Text] [Related]
9. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction.
Smith JB; Ingerman C; Kocsis JJ; Silver MJ
J Clin Invest; 1974 May; 53(5):1468-72. PubMed ID: 4825236
[TBL] [Abstract][Full Text] [Related]
10. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
Joseph S; Krishnamurthi S; Kakkar VV
Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
[TBL] [Abstract][Full Text] [Related]
11. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis.
Parks WM; Hoak JC; Czervionke RL
J Pharmacol Exp Ther; 1981 Nov; 219(2):415-9. PubMed ID: 7026767
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Pedersen AK; FitzGerald GA
Clin Pharmacol Ther; 1985 Jan; 37(1):36-42. PubMed ID: 3917387
[TBL] [Abstract][Full Text] [Related]
14. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
[TBL] [Abstract][Full Text] [Related]
15. Effects of mitoxantrone and bisantrene on platelet aggregation and prostaglandin/thromboxane biosynthesis in vitro.
Frank P; Novak RF
Anticancer Res; 1986; 6(5):941-7. PubMed ID: 3467648
[TBL] [Abstract][Full Text] [Related]
16. Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells.
Eldor A; Polliack G; Vlodavsky I; Levy M
Thromb Haemost; 1983 Apr; 49(2):132-7. PubMed ID: 6346571
[TBL] [Abstract][Full Text] [Related]
17. Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
McDonald JW; Stuart RK; Barnett HJ
Adv Exp Med Biol; 1977; 82():222-4. PubMed ID: 920363
[No Abstract] [Full Text] [Related]
18. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
Fiedel BA; Gewurz H
J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]